| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2362.1989.TB00262.X |
| P698 | PubMed publication ID | 2511024 |
| P2093 | author name string | Breimer DD | |
| Schellens JH | |||
| van der Wart JH | |||
| van der Velde EA | |||
| Janssens AR | |||
| P2860 | cites work | The disposition of antipyrine and its metabolites in young and elderly healthy volunteers | Q34416893 |
| Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach | Q34418061 | ||
| Pharmacokinetics of theophylline: a dose-range study | Q34511493 | ||
| Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis | Q42040905 | ||
| Theophylline kinetics in relation to age: the importance of smoking | Q43243670 | ||
| Histological changes in the liver and indices of drug metabolism in alcoholics | Q44785965 | ||
| Fitting straight lines when both variables are subject to error | Q52795595 | ||
| Overnight salivary caffeine clearance: a liver function test suitable for routine use. | Q53692613 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 472-479 | |
| P577 | publication date | 1989-10-01 | |
| P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
| P1476 | title | Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach | |
| P478 | volume | 19 |
| Q42758567 | A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution |
| Q68158363 | Disposition of antipyrine in patients with extensive metastatic liver disease |
| Q28379555 | Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients |
| Q44344935 | Effects of liver disease on the disposition of the opioid antagonist nalmefene |
| Q35824374 | Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism |
| Q34346052 | Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis |
| Q47722127 | Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6. |
| Q30963437 | Solid phase extraction and simultaneous high performance liquid chromatographic determination of antipyrine and its major metabolites in urine |
| Q70490332 | The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women |
| Q73846452 | Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes |
Search more.